Evidence map›Paper›PMID 32220373›Full record

ArticleClinical nutrition ESPEN2020

Can individuals with celiac disease identify gluten-free foods correctly?

Emily D Gutowski, Dayna Weiten, Kathy H Green, Lisa N Rigaux, Charles N Bernstein, Lesley A Graff, John R Walker, Donald R Duerksen, Jocelyn A Silvester

Abstract read
In one paragraph

Article in Clinical nutrition ESPEN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Developing a Measure to Assess General Knowledge for Coeliac Disease.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  2. Review
  3. Article
  4. Dietary assessments in individuals living with coeliac disease: key considerations.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. New Developments in Celiac Disease Treatment.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emily D GutowskiCeliac Research Program, Harvard Medical School, Boston, MA, United States. Electronic address: emily_gutowski@hms.harvard.edu.
Dayna WeitenWinnipeg Regional Health Authority, Winnipeg, Canada. Electronic address: dweiten@ggh.mb.ca.
Kathy H GreenWinnipeg Regional Health Authority, Winnipeg, Canada; St. Boniface Hospital Research Center, Winnipeg, Canada. Electronic address: kgreen@sbgh.mb.ca.
Lisa N RigauxSt. Boniface Hospital Research Center, Winnipeg, Canada. Electronic address: lrigaux2@sbgh.mb.ca.
Charles N BernsteinWinnipeg Regional Health Authority, Winnipeg, Canada; Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: Charles.bernstein@umanitoba.ca.
Lesley A GraffCeliac Research Program, Harvard Medical School, Boston, MA, United States; Winnipeg Regional Health Authority, Winnipeg, Canada; Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: lgraff@exchange.hsc.mb.ca.
John R WalkerWinnipeg Regional Health Authority, Winnipeg, Canada; St. Boniface Hospital Research Center, Winnipeg, Canada; Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: john.walker@umanitoba.ca.
Donald R DuerksenWinnipeg Regional Health Authority, Winnipeg, Canada; St. Boniface Hospital Research Center, Winnipeg, Canada; Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. Electronic address: dduerkse@sbgh.mb.ca.
Jocelyn A SilvesterCeliac Research Program, Harvard Medical School, Boston, MA, United States; Winnipeg Regional Health Authority, Winnipeg, Canada; St. Boniface Hospital Research Center, Winnipeg, Canada; Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Boston Children's Hospital, Boston, MA, United States. Electronic address: jocelyn.silvester@childrens.harvard.edu.

Funding

RESEARCH TRAINING IN GASTROENTEROLOGYT32DK007760 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KELLY, CIARAN P · 1999 to 2019
$4.6M
Mechanisms and Markers of Small Intestinal Epithelial Injury and Villous AtrophyK23DK119584 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI SILVESTER, JOCELYN ANNE · 2019 to 2023
$971k
CIHRNIDDK NIH HHS K23 DK119584NIDDK NIH HHS T32 DK007760
6 · The paper itself

Abstract

BACKGROUND &

aimsPatients with celiac disease (CD) often report inadvertent gluten exposures and challenges reading labels. The most common cause of non-responsive CD is gluten exposure. We aimed to assess whether recently diagnosed CD patients can determine whether a food is gluten-free based on labeling, and to assess skills over time. A secondary aim was to identify factors associated with label reading proficiency.

methodsInception cohort with follow-up at 6, 12, and 24 months after diagnosis. Participants were asked to determine whether 25 food items were gluten-free based on labeling information. Diet adherence was assessed using the Celiac Diet Assessment Tool (CDAT) and the Gluten-Free Eating Assessment Tool (GF-EAT). 144 adults with newly diagnosed celiac disease were enrolled. The initial quiz at 6 months was completed by 83%. Quizzes were completed by 72% at 12 months and 70% at 24 months.

resultsMedian overall accuracy scores were: 23/25, 24/25 and 21/25 at 6, 12 and 24 months respectively. Gluten-free products with explicit "gluten-free" claims had the fewest errors. Quiz scores were not correlated with tTG IgA levels, or CDAT or GF-EAT scores. Diet adherence was generally good (>85% with CDAT <13 suggesting adequate GFD adherence); however, at 24 months, only 11% reported no gluten exposure.

conclusionsCD patients may be unable to consistently choose gluten-free foods based on product labeling. Explicit identification of gluten-free products may be helpful. Label reading ability appears stable over time. Further studies are needed to evaluate whether erroneous label reading or misleading labels are associated with persistent villous atrophy.

Indexed as

Diet, Gluten-FreeGlutensAdultCeliac DiseaseFemaleFood IngredientsFood LabelingFood MarketsHumansLongitudinal StudiesMaleMiddle AgedNutrition AssessmentPatient ComplianceProspective StudiesSurveys and QuestionnairesFood IngredientsGlutensCeliac diseaseFollow-upFood labelingGluten-free dietTreatment adherence and compliance

Identifiers

PMID32220373
PMCPMC7322618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.